View Older Stories View More Recent Stories

Mar 31, 2026 06:57AM Novo Nordisk cuts Ozempic and Wegovy prices up to 48% in India

Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'

Mar 30, 2026 08:24AM BMO Capital Checking In With Novo Nordisk (NVO) Ahead of 1Q26

Mar 29, 2026 10:00AM Should you buy the dip in Novo Nordisk stock? Wall Street analyst answers

Mar 27, 2026 05:12AM Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'

Mar 26, 2026 05:34AM Wolfe Research Starts Novo Nordisk (NOVOB:DC) (NVO) at Peerperform, 'no longer an obesity darling'

Mar 25, 2026 06:16AM Novo Nordisk (NVO) call put ratio 1.5 calls to 1 put

Mar 20, 2026 07:31AM India's Eris Lifesciences launches generic semaglutide at $13.8 per month

Mar 19, 2026 11:42AM Novo Nordisk gets FDA approval for higher-dose Wegovy HD weight-loss drug

Mar 18, 2026 01:50PM Bernstein SocGen Group Starts Novo Nordisk (NOVOB:DC) (NVO) at Underperform

Mar 18, 2026 08:55AM HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk

Mar 16, 2026 10:32AM Leerink on Structure Therapeutics (GPCR): 'Oral GLP-1 Achieves Best-In-Class Weight Loss'

Mar 13, 2026 10:09AM Hims shares set for best week on record after new Novo Nordisk deal

Mar 10, 2026 09:38AM Novo Nordisk issued FDA warning letter over adverse event reporting

Mar 10, 2026 08:50AM BMO Capital Shares Thoughts on Novo Nordisk (NVO) Following The Hims Agreement

Mar 10, 2026 08:27AM Novo Nordisk downgraded as pipeline 'not poised to blunt semaglutide LOE'

Mar 10, 2026 03:00AM TD Cowen Downgrades Novo Nordisk (NVO) to Hold

Mar 9, 2026 12:23PM TD Cowen: 'Wegovy Injection may be declining'

Mar 9, 2026 08:30AM HIMS partners with Novo Nordisk, shifts US weight loss strategy

Mar 9, 2026 06:53AM Hims soars 44% on report Novo Nordisk to sell weight-loss drugs on its platform

Mar 3, 2026 04:02PM FDA issues 30 warning letters to telehealth firms over GLP-1 claims

Mar 3, 2026 06:54AM Morgan Stanley upgrades Novo Nordisk, says risks better priced after sell-off

Mar 3, 2026 02:56AM Morgan Stanley Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Equalweight

Mar 2, 2026 06:46AM Novo Nordisk to invest $506 million in Ireland facility expansion

Mar 2, 2026 02:51AM Goldman Sachs Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Neutral

Feb 28, 2026 12:15PM FDA approves Novo Nordisk's Sogroya for three new pediatric conditions

Feb 24, 2026 10:11AM BofA on Eli Lilly (LLY): 'Novo’s GLP-1 price update unlikely to ‘rock the boat’'

Feb 24, 2026 07:48AM Eli Lilly falls 2% on Novo Nordisk price cut plans

Feb 24, 2026 07:41AM Novo To Cut Ozempic, Wegovy's US List Prices By Up To 50% - WSJ

Feb 24, 2026 07:31AM Novo Nordisk To Cut Ozempic List Price By 34% - WSJ

Feb 24, 2026 03:44AM Kepler Cheuvreux Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 24, 2026 03:25AM Deutsche Bank Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 24, 2026 12:35AM JPMorgan Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Neutral

Feb 23, 2026 05:56AM Novo Nordisk's CagriSema fails to match tirzepatide in obesity trial

Feb 23, 2026 05:40AM Novo Nordisk (NVO) -13% after 'worst case' REDEFINE-4 readout; LLY +4%

Feb 23, 2026 05:10AM Novo Nordisk (NVO) call put ratio 1 call to 1 put as share price down before the bell

Feb 23, 2026 05:09AM Stocks expected to have increasing option volume: NVO USO XOM CVX SLV GDX DBX AKAM RNG MSTR TXRH LZ VNDA DPX

Feb 22, 2026 03:00PM Hims & Hers Health (HIMS) stock: Should you buy the dip after massive selloff?

Feb 17, 2026 08:59AM European Commission approves higher 7.2 mg dose of Novo Nordisk's Wegovy

Feb 12, 2026 07:12AM Jefferies lifts Novo Nordisk rating as downside risks crystallize

Feb 12, 2026 03:45AM Jefferies Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Feb 11, 2026 06:41AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK400 at Deutsche Bank

Feb 9, 2026 10:15AM FDA flags Novo Nordisk Wegovy pill advertisement as misleading

Feb 9, 2026 09:21AM TD Cowen: 'Good News for Novo Nordisk (NVO), but Impact Uncertain'

Feb 9, 2026 08:26AM Hims and Hers (HIMS) PT Lowered to $20 at Leerink Partners

Feb 9, 2026 07:00AM Novo Nordisk sues Hims & Hers over compounded semaglutide products

Feb 9, 2026 06:53AM Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill

Feb 9, 2026 06:10AM Novo Nordisk (NVO) call put ratio 1.4 calls to 1 put into share price up before the bell

Feb 9, 2026 04:45AM Hims & Hers Health (HIMS) said to stop offering weight loss pill

Feb 6, 2026 04:51PM FDA moves to restrict copycat GLP-1 weight loss drugs

View More Recent Stories View Older Stories